Cite
HARVARD Citation
Tilly, H. et al. (2018). Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study. Lancet. 5 (9), pp. e403-e410. [Online].